ELMMB logo
Facebook logo Twitter logo
Menu

2.0 Cardiovascular

2.0 Cardiovascular

Useful Guidelines and Information

Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
MHRA Drug Safety Update: Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in 
                                                   patients with renal impairment [Published May 2023]
DOAC dosing in renal impairment - SPS 0919
Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline 
Isosorbide Mononitrate - Conversion to Modified Release ELHE
Tranexamic Acid Topical Use to control surface bleeding from fungating wounds in the skin
Ivabradine Prescribing Information Sheet v2.1
Omega 3 Fatty Acid Compounds v2.01
Clopidogrel for Stroke or Mini Stroke - Patient Information Leaflet
Ivabradine in chronic stable angina: Prescribing Guide for GP's
Ranolazine: Prescribing Guide for GP's


NICE Clinical Guidance
 NICE CG95      Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
 NICE NG106   Chronic heart failure in adults: diagnosis and management
 NICE NG136   Hypertension in adults: diagnosis and management
 NICE CG181    Cardiovascular disease: risk assessment and reduction, including lipid modification
 NICE NG185    Acute coronary syndromes [updates and replaces NICE CG167NICE CG172  ]
 NICE CG187    Acute heart failure: diagnosis and management
 NG203            Chronic kidney disease in adults: assessment and management [updates and replaces NICE CG182 ]